Democratic congressmen proposed a legislative solution Thursday for marijuana businesses struggling to stay afloat due to the economic impact of the ongoing coronavirus pandemic.
This week, the federal government announced it would begin processing dozens of pending applications for the “steps necessary to improve access to marijuana research.”
Federal officials would be blocked from punishing banks for working with marijuana businesses under an annual spending bill released by congressional Democratic leaders on Sunday.
At the close of 2018, the U.S. Surgeon General Jerome Adams made a bold move, and called on the federal government to rethink marijuana’s classification as a Schedule I substance.
When the Controlled Substances Act (CSA) passed almost 50 years ago, it created a classification system, known as drug schedules, that prescribe how the federal government views and responds to specific drug compounds.
Employers argue they need clarity on workplace drug-testing rules due to conflicting court decisions on whether random drug-testing regimes are constitutional.